Stem Cell-Based Therapies in Chagasic Cardiomyopathy

Abstract EN

Chagas disease is caused by Trypanosoma cruzi and can lead to a dilated cardiomyopathy decades after the prime infection by the parasite.

As with other dilated cardiomyopathies, conventional pharmacologic therapies are not always effective and as heart failure progresses patients need heart transplantation.

Therefore alternative therapies are highly desirable and cell-based therapies have been investigated in preclinical and clinical studies.

In this paper we review the main findings of such studies and discuss future directions for stem cell-based therapies in chronic chagasic cardiomyopathy.